{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:57:39Z","timestamp":1790614659181,"version":"4.1.0"},"reference-count":270,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.pharma.2026.01.007","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T17:07:44Z","timestamp":1770311264000},"page":"559-594","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["A review exploring the translational perspective of artificial intelligence in drug discovery and formulation development"],"prefix":"10.1016","volume":"84","author":[{"given":"Babita","family":"Agarwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Gaware","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namdev","family":"More","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rushikesh","family":"Shinde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagalavadi Nanjappa","family":"Shivakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5714-5508","authenticated-orcid":false,"given":"Sachin","family":"Jagdale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharma.2026.01.007_bib1000","doi-asserted-by":"crossref","first-page":"770","DOI":"10.3389\/fphar.2020.00770","article-title":"Accelerating therapeutics for opportunities in medicine: a paradigm shift in drug discovery","volume":"11","author":"Hinkson","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pharma.2026.01.007_bib1005","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3389\/fphar.2020.00733","article-title":"Discovering anti-cancer drugs via computational methods","volume":"11","author":"Cui","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pharma.2026.01.007_bib1010","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nrd.2017.244","article-title":"Impact of a five-dimensional framework on R&D productivity at AstraZeneca","volume":"17","author":"Morgan","year":"2018","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"10.1016\/j.pharma.2026.01.007_bib1015","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41408-020-0338-x","article-title":"The high cost of prescription drugs: causes and solutions","volume":"10","author":"Rajkumar","year":"2020","journal-title":"Blood Cancer J"},{"issue":"10","key":"10.1016\/j.pharma.2026.01.007_bib1020","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.2174\/1568026033452096","article-title":"The role of absorption, distribution, metabolism, excretion and toxicity in drug discovery","volume":"3","author":"Lin","year":"2003","journal-title":"Curr Top Med Chem"},{"issue":"14","key":"10.1016\/j.pharma.2026.01.007_bib1025","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.2174\/138161207780765954","article-title":"Artificial intelligence approaches for rational drug design and discovery","volume":"13","author":"Duch","year":"2007","journal-title":"Curr Pharm Des"},{"issue":"11","key":"10.1016\/j.pharma.2026.01.007_bib1030","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.drudis.2017.08.010","article-title":"From machine learning to deep learning: progress in machine intelligence for rational drug discovery","volume":"22","author":"Zhang","year":"2017","journal-title":"Drug Discov Today"},{"issue":"8","key":"10.1016\/j.pharma.2026.01.007_bib1035","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.clinthera.2019.05.018","article-title":"A study on the application and use of artificial intelligence to support drug development","volume":"41","author":"Lamberti","year":"2019","journal-title":"Clin Ther"},{"key":"10.1016\/j.pharma.2026.01.007_bib1040","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1056\/NEJMra1814259","article-title":"Machine learning in medicine","volume":"380","author":"Rajkomar","year":"2019","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.pharma.2026.01.007_bib1045","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3390\/life14020233","article-title":"Integrating artificial intelligence for drug discovery in the context of revolutionizing drug delivery","volume":"14","author":"Visan","year":"2024","journal-title":"Life"},{"key":"10.1016\/j.pharma.2026.01.007_bib1050","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.indmarman.2017.12.019","article-title":"Waiting for a sales renaissance in the fourth industrial revolution: machine learning and artificial intelligence in sales research and practice","volume":"69","author":"Syam","year":"2018","journal-title":"Ind Mark Manag"},{"key":"10.1016\/j.pharma.2026.01.007_bib1055","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41573-019-0050-3","article-title":"Rethinking drug design in the artificial intelligence era","volume":"19","author":"Schneider","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.pharma.2026.01.007_bib1060","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s40537-019-0217-0","article-title":"Big data in healthcare: management, analysis and future prospects","volume":"6","author":"Dash","year":"2019","journal-title":"J Big Data"},{"issue":"8","key":"10.1016\/j.pharma.2026.01.007_bib1065","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1021\/acs.jcim.7b00146","article-title":"Is multitask deep learning practical for pharma?","volume":"57","author":"Ramsundar","year":"2017","journal-title":"J Chem Inf Model"},{"issue":"9","key":"10.1016\/j.pharma.2026.01.007_bib1070","doi-asserted-by":"crossref","first-page":"622","DOI":"10.2174\/0113892002265786230921062205","article-title":"Artificial intelligence in drug formulation and development: applications and future prospects","volume":"24","author":"Noorain","year":"2023","journal-title":"Curr Drug Metab"},{"issue":"5","key":"10.1016\/j.pharma.2026.01.007_bib1075","first-page":"295","article-title":"The use of artificial intelligence in pharmacovigilance: a systematic review of the literature","volume":"36","author":"Salas","year":"2022","journal-title":"Pharmaceut Med"},{"issue":"1","key":"10.1016\/j.pharma.2026.01.007_bib1080","doi-asserted-by":"crossref","first-page":"12236","DOI":"10.1038\/s41598-024-62567-1","article-title":"ClinicalGAN: powering patient monitoring in clinical trials with patient digital twins","volume":"14","author":"Chandra","year":"2024","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.pharma.2026.01.007_bib1085","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.drudis.2020.10.010","article-title":"Artificial intelligence in drug discovery and development","volume":"26","author":"Paul","year":"2020","journal-title":"Drug Discov Today"},{"issue":"4","key":"10.1016\/j.pharma.2026.01.007_bib1090","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/cpt.1795","article-title":"Will artificial intelligence for drug discovery impact clinical pharmacology","volume":"107","author":"Zhavoronkov","year":"2020","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharma.2026.01.007_bib1095","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.2174\/1381612828666220608141049","article-title":"Application of artificial intelligence in drug discovery","volume":"28","author":"Chopra","year":"2022","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.pharma.2026.01.007_bib1100","first-page":"582","article-title":"A deep learning approach to antibiotic discovery","volume":"578","author":"Stokes","year":"2020","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.pharma.2026.01.007_bib1105","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrd.2017.232","article-title":"Automating drug discovery","volume":"17","author":"Schneider","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.pharma.2026.01.007_bib1110","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.cell.2015.08.063","article-title":"CDK7-dependent transcriptional addiction in triple-negative breast cancer","volume":"163","author":"Wang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.pharma.2026.01.007_bib1115","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s44395-025-00007-3","article-title":"Artificial intelligence in drug discovery and development: transforming challenges into opportunities","volume":"1","author":"Schneider","year":"2025","journal-title":"Discov Pharm Sci"},{"key":"10.1016\/j.pharma.2026.01.007_bib1120","series-title":"Exscientia and GT Apeiron Therapeutics Enter Oncology Joint Venture. Press Release","year":"2021"},{"issue":"8","key":"10.1016\/j.pharma.2026.01.007_bib1125","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.3390\/ijms21082974","article-title":"Blockade of CDK7 reverses endocrine therapy resistance in breast cancer","volume":"21","author":"Attia","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.pharma.2026.01.007_bib1130","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41591-018-0300-7","article-title":"High-performance medicine: the convergence of human and artificial intelligence","volume":"25","author":"Topol","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.pharma.2026.01.007_bib1135","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/s41587-019-0224-x","article-title":"Deep learning enables rapid identification of potent DDR1 kinase inhibitors","volume":"37","author":"Zhavoronkov","year":"2019","journal-title":"Nat Biotechnol"},{"issue":"1","key":"10.1016\/j.pharma.2026.01.007_bib1140","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.drudis.2020.10.010","article-title":"Artificial intelligence in drug discovery and development","volume":"26","author":"Paul","year":"2021","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.pharma.2026.01.007_bib1145","doi-asserted-by":"crossref","first-page":"115108","DOI":"10.1016\/j.addr.2023.115108","article-title":"Revolutionizing drug formulation development: the increasing impact of machine learning","volume":"202","author":"Bao","year":"2023","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.pharma.2026.01.007_bib1150","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.csbj.2014.11.005","article-title":"Machine learning applications in cancer prognosis and prediction","volume":"13","author":"Kourou","year":"2015","journal-title":"Comput Struct Biotechnol J"},{"key":"10.1016\/j.pharma.2026.01.007_bib1155","doi-asserted-by":"crossref","first-page":"100288","DOI":"10.1016\/j.health.2023.100288","article-title":"Supervised and unsupervised learning models for pharmaceutical drug rating and classification using consumer generated reviews","volume":"5","author":"Allenbrand","year":"2024","journal-title":"Healthc Anal"},{"issue":"1","key":"10.1016\/j.pharma.2026.01.007_bib1160","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1747-0285.2012.01444.x","article-title":"Patient-specific modelling in drug design, development and selection including its role in clinical decision-making","volume":"81","author":"Shublaq","year":"2013","journal-title":"Chem Biol Drug Des"},{"issue":"1","key":"10.1016\/j.pharma.2026.01.007_bib1165","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2174\/1875036201307010049","article-title":"Artificial neural network in drug delivery and pharmaceutical research","volume":"7","author":"Sutariya","year":"2013","journal-title":"Open Bioinform J"},{"issue":"4","key":"10.1016\/j.pharma.2026.01.007_bib1170","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1208\/s12249-012-9836-x","article-title":"Quality by design approach: application of artificial intelligence techniques of tablets manufactured by direct compression","volume":"13","author":"Aksu","year":"2012","journal-title":"AAPS Pharm Sci Tech"},{"issue":"1","key":"10.1016\/j.pharma.2026.01.007_bib1175","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.apsb.2018.09.010","article-title":"Deep learning for in vitro prediction of pharmaceutical formulations","volume":"9","author":"Yang","year":"2019","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.pharma.2026.01.007_bib1180","series-title":"Formulation tools for pharmaceutical development","first-page":"109","article-title":"SeDeM Diagram: an expert system for preformation, characterization and optimization of tablets obtained by direct compression","author":"Su\u00f1\u00e9 Negre","year":"2013"},{"issue":"1","key":"10.1016\/j.pharma.2026.01.007_bib1185","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.eswa.2004.08.003","article-title":"Expert system methodologies and applications\u00a0\u2013\u00a0a decade review from 1995 to 2004","volume":"28","author":"Liao","year":"2005","journal-title":"Expert Syst Appl"},{"issue":"1","key":"10.1016\/j.pharma.2026.01.007_bib1190","doi-asserted-by":"crossref","first-page":"114900","DOI":"10.1016\/j.eswa.2021.114900","article-title":"Expert systems: definitions, advantages and issues in medical field applications","volume":"177","author":"Saibene","year":"2021","journal-title":"Expert Syst Appl"},{"issue":"3","key":"10.1016\/j.pharma.2026.01.007_bib1195","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.3906\/elk-2008-27","article-title":"A fuzzy expert system for predicting the mortality of COVID-19","volume":"29","author":"Mangla","year":"2021","journal-title":"Turk J Electr Eng Comput Sci"},{"key":"10.1016\/j.pharma.2026.01.007_bib1200","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10845-008-0226-x","article-title":"Determination of the drug dose by fuzzy expert system in treatment of chronic intestine inflammation","volume":"20","author":"Saritas","year":"2009","journal-title":"J Intell Manuf"},{"key":"10.1016\/j.pharma.2026.01.007_bib1205","series-title":"Artificial intelligence in medicine: technical basis and clinical applications","first-page":"75","article-title":"Expert systems in medicine","author":"Zhou","year":"2021"},{"issue":"1","key":"10.1016\/j.pharma.2026.01.007_bib1210","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2174\/157489308783329869","article-title":"Medical expert systems","volume":"3","author":"Vihinen","year":"2008","journal-title":"Curr Bioinform"},{"key":"10.1016\/j.pharma.2026.01.007_bib1215","doi-asserted-by":"crossref","unstructured":"Colombo S. Applications of artificial intelligence in drug delivery and pharmaceutical development. Artificial intelligence in healthcare. Academic Press London, United Kingdom; 2020. p. 85\u2013116. [https:\/\/doi.org\/10.1016\/B978-0-12-818438-7.00004-6].","DOI":"10.1016\/B978-0-12-818438-7.00004-6"},{"key":"10.1016\/j.pharma.2026.01.007_bib1220","doi-asserted-by":"crossref","first-page":"406","DOI":"10.5001\/omj.2015.82","article-title":"The applications of genetic algorithms in medicine","volume":"30","author":"Ghaheri","year":"2015","journal-title":"Oman Med J"},{"issue":"12","key":"10.1016\/j.pharma.2026.01.007_bib1225","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1016\/j.xphs.2016.08.018","article-title":"On the design of a fuzzy logic\u2013based control system for freeze-drying processes","volume":"105","author":"Fissore","year":"2016","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.pharma.2026.01.007_bib1230","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0032-5910(94)02880-X","article-title":"Application of fuzzy logic to bed height control in agitation-fluidized bed granulation","volume":"81","author":"Watano","year":"1994","journal-title":"Powder Technol"},{"key":"10.1016\/j.pharma.2026.01.007_bib1235","first-page":"7","article-title":"Role of computational intelligence in drugs discovery and design: introduction, techniques and software","volume":"51","author":"Yadav","year":"2012","journal-title":"Int J Comput Appl"},{"issue":"7","key":"10.1016\/j.pharma.2026.01.007_bib1240","doi-asserted-by":"crossref","first-page":"103","DOI":"10.23883\/IJRTER.2018.4363.PDT1C","article-title":"Analysis of soil nutrients using data mining techniques","volume":"4","author":"Chiranjeevi","year":"2018","journal-title":"Int J Recent Trends Eng Res"},{"key":"10.1016\/j.pharma.2026.01.007_bib1245","doi-asserted-by":"crossref","first-page":"050001","DOI":"10.1063\/5.0062851","article-title":"Analysis of soil nutrients for different crops using data mining techniques","volume":"2364","author":"Samundeeswari","year":"2021","journal-title":"AIP Conf Proc"},{"issue":"5","key":"10.1016\/j.pharma.2026.01.007_bib1250","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1109\/3477.718514","article-title":"Varying fitness functions in genetic algorithm constrained optimization: the Cutting Stock and unit commitment problems","volume":"28","author":"Petridis","year":"1998","journal-title":"IEEE Trans Syst Man Cybern B"},{"key":"10.1016\/j.pharma.2026.01.007_bib1255","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S1359-6446(98)01219-7","article-title":"Evolutionary combinatorial chemistry: application of genetic algorithms","volume":"3","author":"Weber","year":"1998","journal-title":"Drug Discov Today"},{"issue":"6","key":"10.1016\/j.pharma.2026.01.007_bib1260","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/ddr.21211","article-title":"Opportunities and challenges provided by cloud repositories for bioinformatics-enabled drug discovery","volume":"75","author":"Dalp\u00e9","year":"2014","journal-title":"Drug Dev Res"},{"issue":"9","key":"10.1016\/j.pharma.2026.01.007_bib1265","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1080\/17460441.2021.1932812","article-title":"The machine learning life cycle and the cloud: implications for drug discovery","volume":"16","author":"Spjuth","year":"2021","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.pharma.2026.01.007_bib1270","first-page":"87","article-title":"Genetic programming: on the programming of computers by means of natural selection","volume":"4","author":"Koza","year":"1994","journal-title":"Biosystems"},{"key":"10.1016\/j.pharma.2026.01.007_bib1275","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1016\/j.csbj.2021.08.011","article-title":"A review on machine learning approaches and trends in drug discovery","volume":"19","author":"Carracedo-Reboredo","year":"2021","journal-title":"Comput Struct Biotechnol J"},{"key":"10.1016\/j.pharma.2026.01.007_bib1280","series-title":"Analytics for citizen data scientists","article-title":"Predictive analytics with KNIME","author":"Acito","year":"2023"},{"issue":"4","key":"10.1016\/j.pharma.2026.01.007_bib1285","doi-asserted-by":"crossref","first-page":"e22735","DOI":"10.1002\/cae.22735","article-title":"Evaluation of Orange data mining software and examples for lecturing machine learning tasks in geoinformatics","volume":"32","author":"Dobesova","year":"2024","journal-title":"Comput Appl Eng Educ"},{"key":"10.1016\/j.pharma.2026.01.007_bib1290","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.procs.2016.05.251","article-title":"Correlation review of classification algorithm using data mining tool: WEKA, Rapidminer, Tanagra, Orange and Knime","volume":"85","author":"Naik","year":"2016","journal-title":"Procedia Comput Sci"},{"key":"10.1016\/j.pharma.2026.01.007_bib1295","doi-asserted-by":"crossref","first-page":"e1012574","DOI":"10.1371\/journal.pcbi.1012574","article-title":"Hands-on training about data clustering with Orange Data Mining Toolbox","volume":"20","author":"Dem\u0161ar","year":"2024","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.pharma.2026.01.007_bib1300","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1039\/D4CP04309J","article-title":"Navigating the evolution of two-dimensional carbon nitride research: integrating machine learning into conventional approaches","volume":"27","author":"Mondal","year":"2025","journal-title":"Phys Chem Chem Phys"},{"issue":"4","key":"10.1016\/j.pharma.2026.01.007_bib1305","first-page":"651","article-title":"Drug discovery and development: role of basic biological research","volume":"3","author":"Mohs","year":"2017","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.pharma.2026.01.007_bib1310","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s43094-024-00625-1","article-title":"Influence of artificial intelligence in modern pharmaceutical formulation and drug development","volume":"10","author":"Ali","year":"2024","journal-title":"Future J Pharm Sci"},{"issue":"9","key":"10.1016\/j.pharma.2026.01.007_bib1315","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.3390\/ph18091271","article-title":"Artificial intelligence in small-molecule drug discovery: a critical review of methods, applications, and real-world outcomes","volume":"18","author":"Niazi","year":"2025","journal-title":"Pharmaceuticals"},{"issue":"10","key":"10.1016\/j.pharma.2026.01.007_bib1320","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.3390\/molecules23102520","article-title":"Artificial intelligence in drug design","volume":"23","author":"Hessler","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.pharma.2026.01.007_bib1325","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.injury.2006.02.001","article-title":"Grading the evidence: levels of evidence and grades of recommendation","volume":"37","author":"Petrisor","year":"2006","journal-title":"Injury"},{"issue":"20","key":"10.1016\/j.pharma.2026.01.007_bib1330","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJM197711172972004","article-title":"Evidence favoring the use of anticoagulants in the hospital phase of acute myocardial infarction","volume":"297","author":"Chalmers","year":"1977","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.pharma.2026.01.007_bib1335","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/bmsp.12078","article-title":"A tutorial on how to do a Mokken scale analysis on your test and questionnaire data","volume":"70","author":"Sijtsma","year":"2017","journal-title":"Br J Math Stat Psychol"},{"issue":"4","key":"10.1016\/j.pharma.2026.01.007_bib1340","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nchembio.1199","article-title":"Target identification and mechanism of action in chemical biology and drug discovery","volume":"9","author":"Schenone","year":"2013","journal-title":"Nat Chem Biol"},{"issue":"4","key":"10.1016\/j.pharma.2026.01.007_bib1345","doi-asserted-by":"crossref","first-page":"e0176486","DOI":"10.1371\/journal.pone.0176486","article-title":"A novel framework for the identification of drug target proteins: combining stacked auto-encoders with a biased support vector machine","volume":"12","author":"Wang","year":"2017","journal-title":"PLoS One"},{"issue":"Suppl. 24","key":"10.1016\/j.pharma.2026.01.007_bib1350","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1186\/s12859-019-3241-3","article-title":"Biological representation of chemicals using latent target interaction profile","volume":"20","author":"Ayed","year":"2019","journal-title":"BMC Bioinform"},{"issue":"12","key":"10.1016\/j.pharma.2026.01.007_bib1355","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1021\/acs.jpclett.5b00831","article-title":"Machine learning predictions of molecular properties: accurate many-body potentials and nonlocality in chemical space","volume":"6","author":"Hansen","year":"2015","journal-title":"J Phys Chem Lett"},{"issue":"8","key":"10.1016\/j.pharma.2026.01.007_bib1360","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s10822-011-9455-8","article-title":"In silico identification of new ligands for GPR17: a promising therapeutic target for neurodegenerative diseases","volume":"25","author":"Eberini","year":"2011","journal-title":"J Comput Aided Mol Des"},{"issue":"6","key":"10.1016\/j.pharma.2026.01.007_bib1365","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.3390\/ijms19061578","article-title":"Natural products for drug discovery in the 21st century: innovations for novel drug discovery","volume":"19","author":"Thomford","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"16","key":"10.1016\/j.pharma.2026.01.007_bib1370","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1093\/bioinformatics\/btv195","article-title":"PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels","volume":"31","author":"Choi","year":"2015","journal-title":"Bioinformatics"},{"issue":"16","key":"10.1016\/j.pharma.2026.01.007_bib1375","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1093\/bioinformatics\/btv194","article-title":"MetaMapR: pathway independent metabolomic network analysis incorporating unknowns","volume":"31","author":"Grapov","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.pharma.2026.01.007_bib1380","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.csbj.2016.04.004","article-title":"Computational approaches in target identification and drug discovery","volume":"14","author":"Katsila","year":"2016","journal-title":"Comput Struct Biotechnol J"},{"issue":"3","key":"10.1016\/j.pharma.2026.01.007_bib1385","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/jmv.24660","article-title":"Identification of resveratrol analogs as potent anti-dengue agents using a cell-based assay","volume":"89","author":"Han","year":"2017","journal-title":"J Med Virol"},{"issue":"1","key":"10.1016\/j.pharma.2026.01.007_bib1390","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1039\/c0md00020e","article-title":"Chemical space as a source for new drugs","volume":"1","author":"Reymond","year":"2010","journal-title":"Med Chem Commun"},{"issue":"20","key":"10.1016\/j.pharma.2026.01.007_bib1395","doi-asserted-by":"crossref","first-page":"4723","DOI":"10.3390\/molecules25204723","article-title":"Merging ligand-based and structure-based methods in drug discovery: an overview of combined virtual screening approaches","volume":"25","author":"V\u00e1zquez","year":"2020","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.pharma.2026.01.007_bib1400","doi-asserted-by":"crossref","first-page":"e29252","DOI":"10.1371\/journal.pone.0029252","article-title":"Hydroxybenzothiazoles as new nonsteroidal inhibitors of 17\u03b2-hydroxysteroid dehydrogenase type 1 (17\u03b2-HSD1)","volume":"7","author":"Spadaro","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.pharma.2026.01.007_bib1405","doi-asserted-by":"crossref","first-page":"17174","DOI":"10.1038\/s41598-019-53376-y","article-title":"Discovery of novel potential selective HDAC8 inhibitors by combined ligand-based, structure-based virtual screening and in-vitro biological evaluation","volume":"9","author":"Debnath","year":"2019","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.pharma.2026.01.007_bib1410","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1021\/cn3000422","article-title":"Exploring chemical space for drug discovery using the chemical universe database","volume":"3","author":"Reymond","year":"2012","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"10.1016\/j.pharma.2026.01.007_bib1415","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1039\/C4MD00216D","article-title":"Polypharmacology modelling using proteochemometrics (PCM): recent methodological developments, applications to target families, and future prospects","volume":"6","author":"Cort\u00e9s-Ciriano","year":"2015","journal-title":"Med Chem Commun"},{"key":"10.1016\/j.pharma.2026.01.007_bib1420","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.pharma.2026.01.007_bib1425","article-title":"DiffDock: diffusion steps, twists, and turns for molecular docking","author":"Corso","year":"2023","journal-title":"ICLR"},{"issue":"9","key":"10.1016\/j.pharma.2026.01.007_bib1430","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1021\/acs.jcim.1c00600","article-title":"MolGPT: molecular generation using a transformer-decoder model","volume":"62","author":"Bagal","year":"2022","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.pharma.2026.01.007_bib1435","series-title":"Deep learning for the life sciences: applying deep learning to genomics, microscopy, drug discovery, and more","author":"Ramsundar","year":"2019"},{"issue":"37","key":"10.1016\/j.pharma.2026.01.007_bib1440","doi-asserted-by":"crossref","first-page":"38371","DOI":"10.1021\/acsomega.3c10183","article-title":"A novel rational PROTACs design and validation via AI-driven drug design approach","volume":"9","author":"Chou","year":"2024","journal-title":"ACS Omega"},{"issue":"12","key":"10.1016\/j.pharma.2026.01.007_bib1445","doi-asserted-by":"crossref","first-page":"124111","DOI":"10.1063\/5.0021955","article-title":"OrbNet: deep learning for quantum chemistry using symmetry-adapted atomic-orbital features","volume":"153","author":"Qiao","year":"2020","journal-title":"J Chem Phys"},{"issue":"4","key":"10.1016\/j.pharma.2026.01.007_bib1450","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/jmr.744","article-title":"A new strategy for improved secondary screening and lead optimization using high-resolution SPR characterization of compound\u2013target interactions","volume":"18","author":"Huber","year":"2005","journal-title":"J Mol Recognit"},{"issue":"2","key":"10.1016\/j.pharma.2026.01.007_bib1455","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2217\/clp.15.4","article-title":"Translational research on autotaxin-LPA-LPA receptors and drug discovery","volume":"10","author":"Im","year":"2015","journal-title":"Clin Lipidol"},{"key":"10.1016\/j.pharma.2026.01.007_bib1460","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41592-023-01790-6","article-title":"AlphaFold and beyond","volume":"20","author":"Macalino","year":"2023","journal-title":"Nat Methods"},{"key":"10.1016\/j.pharma.2026.01.007_bib1465","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1007\/s12272-015-0640-5","article-title":"Role of computer-aided drug design in modern drug discovery","volume":"38","author":"Macalino","year":"2015","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.pharma.2026.01.007_bib1470","series-title":"QikProp User Manual, version 6.6","year":"2021"},{"key":"10.1016\/j.pharma.2026.01.007_bib1475","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.pharma.2026.01.007_bib1480","series-title":"ADMET Predictor\u2122 Technical Guide, version 10.4","year":"2023"},{"key":"10.1016\/j.pharma.2026.01.007_bib1485","series-title":"Reference module in life sciences","article-title":"Structure-based drug design workflow","author":"Hardianto","year":"2018"},{"key":"10.1016\/j.pharma.2026.01.007_bib1490","article-title":"AtomNet: a deep convolutional neural network for bioactivity prediction in structure-based drug discovery","volume":"arXiv","author":"Wallach","year":"2015","journal-title":"arXiv"},{"key":"10.1016\/j.pharma.2026.01.007_bib1495","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fchem.2018.00030","article-title":"In silico prediction of chemical toxicity for drug design using machine learning methods and structural alerts","volume":"6","author":"Yang","year":"2018","journal-title":"Front Chem"},{"key":"10.1016\/j.pharma.2026.01.007_bib1500","doi-asserted-by":"crossref","first-page":"13196","DOI":"10.1039\/D5SC01778E","article-title":"Guided multi-objective generative AI to enhance structure-based drug design","volume":"16","author":"Zhang Kadan","year":"2025","journal-title":"Chem Sci"},{"key":"10.1016\/j.pharma.2026.01.007_bib1505","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.1021\/acs.jcim.4c00481","article-title":"HydraScreen: a generalizable structure-based deep learning approach to drug discovery","volume":"64","author":"Prat","year":"2024","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.pharma.2026.01.007_bib1510","series-title":"Drug design","article-title":"Protein\u2013ligand interactions as the basis for drug action","author":"Klebe","year":"2024"},{"key":"10.1016\/j.pharma.2026.01.007_bib1515","doi-asserted-by":"crossref","first-page":"6802","DOI":"10.1021\/jm060902w","article-title":"Bridging chemical and biological space: \u201ctarget fishing\u201d using 2D and 3D molecular descriptors","volume":"49","author":"Nettles","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharma.2026.01.007_bib1520","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.addr.2019.05.001","article-title":"The significance of artificial intelligence in drug delivery system design","volume":"151","author":"Hassanzadeh","year":"2019","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.pharma.2026.01.007_bib1525","first-page":"086033","article-title":"Deep learning with feature embedding for compound\u2013protein interaction prediction","volume":"7","author":"Wan","year":"2016","journal-title":"bioRxiv"},{"issue":"7","key":"10.1016\/j.pharma.2026.01.007_bib1530","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/nchembio.398","article-title":"Hypothesis-driven omics integration","volume":"6","author":"Schmid","year":"2010","journal-title":"Nat Chem Biol"},{"issue":"9","key":"10.1016\/j.pharma.2026.01.007_bib1535","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.15252\/embr.201744876","article-title":"The reproducibility \u201ccrisis\u201d: reaction to replication crisis should not stifle innovation","volume":"18","author":"Hunter","year":"2017","journal-title":"EMBO Rep"},{"key":"10.1016\/j.pharma.2026.01.007_bib1540","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s42826-022-00128-1","article-title":"Role of animal models in biomedical research: a review","volume":"38","author":"Mukherjee","year":"2022","journal-title":"Lab Anim Res"},{"key":"10.1016\/j.pharma.2026.01.007_bib1545","doi-asserted-by":"crossref","first-page":"012036","DOI":"10.1088\/1757-899X\/1254\/1\/012036","article-title":"Expending the power of artificial intelligence in preclinical research: an overview","volume":"1254","author":"Diaconu","year":"2022","journal-title":"IOP Conf Ser: Mater Sci Eng"},{"issue":"4","key":"10.1016\/j.pharma.2026.01.007_bib1550","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1158\/0008-5472.CAN-20-0866","article-title":"Assessing drug development risk using big data and machine learning","volume":"81","author":"Vergetis","year":"2021","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharma.2026.01.007_bib1555","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2174\/0109298673290511240404053224","article-title":"Graph neural networks with multi-features for predicting cocrystals using APIs and coformers interactions","volume":"31","author":"Mswahili","year":"2024","journal-title":"Curr Med Chem"},{"issue":"18","key":"10.1016\/j.pharma.2026.01.007_bib1560","doi-asserted-by":"crossref","first-page":"10520","DOI":"10.1021\/acs.chemrev.8b00728","article-title":"Concepts of artificial intelligence for computer-assisted drug discovery","volume":"119","author":"Yang","year":"2019","journal-title":"Chem Rev"},{"key":"10.1016\/j.pharma.2026.01.007_bib1565","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1152\/physiolgenomics.00011.2024","article-title":"Artificial intelligence and omics in malignant gliomas","volume":"56","author":"Tambi","year":"2024","journal-title":"Physiol Genomics"},{"key":"10.1016\/j.pharma.2026.01.007_bib1570","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.tips.2019.06.004","article-title":"Advancing drug discovery via artificial intelligence","volume":"40","author":"Chan","year":"2019","journal-title":"Trends Pharmacol Sci"},{"issue":"13","key":"10.1016\/j.pharma.2026.01.007_bib1575","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1021\/jm8000373","article-title":"Recent developments in fragment-based drug discovery","volume":"51","author":"Congreve","year":"2008","journal-title":"J Med Chem"},{"issue":"10","key":"10.1016\/j.pharma.2026.01.007_bib1580","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.3390\/molecules23102520","article-title":"Artificial intelligence in drug design","volume":"23","author":"Hessler","year":"2018","journal-title":"Molecules"},{"issue":"3902","key":"10.1016\/j.pharma.2026.01.007_bib1585","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1126\/science.166.3902.178","article-title":"Computer-assisted design of complex organic syntheses: pathways for molecular synthesis can be devised with a computer and equipment for graphical communication","volume":"166","author":"Corey","year":"1969","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.pharma.2026.01.007_bib1590","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.chempr.2018.02.024","article-title":"Chematica: a story of computer code that started to think like a chemist","volume":"4","author":"Grzybowski","year":"2018","journal-title":"Chemistry"},{"issue":"7","key":"10.1016\/j.pharma.2026.01.007_bib1595","doi-asserted-by":"crossref","first-page":"eaap7885","DOI":"10.1126\/sciadv.aap7885","article-title":"Deep reinforcement learning for de novo drug design","volume":"4","author":"Popova","year":"2018","journal-title":"Sci Adv"},{"issue":"3","key":"10.1016\/j.pharma.2026.01.007_bib1600","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.drudis.2018.11.014","article-title":"Artificial intelligence in drug development: present status and future prospects","volume":"24","author":"Mak","year":"2019","journal-title":"Drug Discov Today"},{"issue":"4","key":"10.1016\/j.pharma.2026.01.007_bib1605","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1208\/s12249-021-02026-6","volume":"22","author":"Rahman","year":"2021","journal-title":"AAPS Pharm Sci Tech"},{"key":"10.1016\/j.pharma.2026.01.007_bib1610","unstructured":"FDA. Artificial intelligence in drug manufacturing. FDA.gov. [accessed April 11, 2024. https:\/\/www.fda.gov\/media\/165743\/download]."},{"key":"10.1016\/j.pharma.2026.01.007_bib1615","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1208\/s12248-022-00706-0","article-title":"Application of artificial neural networks in the process analytical technology of pharmaceutical manufacturing\u2014A review","volume":"24","author":"Nagy","year":"2022","journal-title":"AAPS J"},{"key":"10.1016\/j.pharma.2026.01.007_bib1620","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF02784878","article-title":"Toward intelligent decision support for pharmaceutical product development","volume":"1","author":"Zhao","year":"2006","journal-title":"J Pharm Innov"},{"key":"10.1016\/j.pharma.2026.01.007_bib1625","doi-asserted-by":"crossref","first-page":"E449","DOI":"10.1208\/pt060356","article-title":"Generalization of a prototype intelligent hybrid system for hard gelatin capsule formulation development","volume":"6","author":"Wilson","year":"2005","journal-title":"AAPS Pharm Sci Tech"},{"key":"10.1016\/j.pharma.2026.01.007_bib1630","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3390\/pr11010119","article-title":"Particle scale insights into a KG-pharma RoTab tablet press feed-frame system using the discrete element method (DEM) modeling","volume":"11","author":"Li","year":"2023","journal-title":"Processes"},{"key":"10.1016\/j.pharma.2026.01.007_bib1635","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3390\/pharmaceutics14030673","article-title":"Finite element analysis and modeling in pharmaceutical tableting","volume":"14","author":"Partheniadis","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.pharma.2026.01.007_bib1640","doi-asserted-by":"crossref","first-page":"120338","DOI":"10.1016\/j.ijpharm.2021.120338","article-title":"Real-time release testing of dissolution based on surrogate models developed by machine learning algorithms using NIR spectra, compression force and particle size distribution as input data","volume":"597","author":"Galata","year":"2021","journal-title":"Int J Pharm"},{"key":"10.1016\/j.pharma.2026.01.007_bib1645","series-title":"Formulation tools for pharmaceutical development","first-page":"137","article-title":"6-New SeDeM-ODT expert system: an expert system for formulation of orodispersible tablets obtained by direct compression","author":"Aguilar","year":"2013"},{"key":"10.1016\/j.pharma.2026.01.007_bib1650","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2174\/2589977512666200928113716","article-title":"SeDeM expert system, an innovative tool for developing directly compressible tablets: a review","volume":"13","author":"Singh","year":"2021","journal-title":"Curr Drug Res Rev"},{"key":"10.1016\/j.pharma.2026.01.007_bib1655","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ejpb.2006.06.008","article-title":"A new expert system (SeDeM Diagram) for control batch powder formulation and preformulation drug products","volume":"64","author":"P\u00e9rez","year":"2006","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.pharma.2026.01.007_bib1660","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ejpb.2020.05.012","article-title":"Artificial neural networks applied to quality-by-design: from formulation development to clinical outcome","volume":"152","author":"Sim\u00f5es","year":"2020","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.pharma.2026.01.007_bib1665","first-page":"622","article-title":"Artificial intelligence in smart drug delivery systems: a step toward personalized medicine","volume":"24","author":"Panchpuri","year":"2025","journal-title":"RSC Pharm"},{"key":"10.1016\/j.pharma.2026.01.007_bib1670","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.yrtph.2014.11.011","article-title":"Estimation of the chemical-induced eye injury using a weight-of-evidence (WoE) battery of 21 artificial neural network (ANN) c-QSAR models (QSAR-21): part I: irritation potential","volume":"71","author":"Verma","year":"2015","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.pharma.2026.01.007_bib1675","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1021\/acs.molpharmaceut.6b00471","article-title":"ADMET evaluation in drug discovery. 16. Predicting hERG blockers by combining multiple pharmacophores and machine learning approaches","volume":"13","author":"Wang","year":"2016","journal-title":"Mol Pharm"},{"key":"10.1016\/j.pharma.2026.01.007_bib1680","doi-asserted-by":"crossref","first-page":"121411","DOI":"10.1016\/j.ijpharm.2021.121411","article-title":"QbD guided development of immediate release FDM-3D printed tablets with customizable API doses","volume":"613","author":"Cri\u0219an","year":"2022","journal-title":"Int J Pharm"},{"key":"10.1016\/j.pharma.2026.01.007_bib1685","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jconrel.2024.12.043","article-title":"AI-directed formulation strategy design initiates rational drug development","volume":"378","author":"Wang","year":"2025","journal-title":"J Control Release"},{"key":"10.1016\/j.pharma.2026.01.007_bib1690","doi-asserted-by":"crossref","first-page":"123001","DOI":"10.1016\/j.ijpharm.2023.123001","article-title":"Convolutional neural network-based evaluation of chemical maps obtained by fast Raman imaging for prediction of tablet dissolution profiles","volume":"640","author":"Galata","year":"2023","journal-title":"Int J Pharm"},{"key":"10.1016\/j.pharma.2026.01.007_bib1695","first-page":"412","article-title":"Real-time decision making for digital twin in additive manufacturing with model predictive control using time-series deep neural networks","volume":"80","author":"Chen","year":"2025","journal-title":"arXiv"},{"key":"10.1016\/j.pharma.2026.01.007_bib1700","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1007\/s00170-019-03332-x","article-title":"A critical review of fused deposition modelling 3D printing technology in manufacturing polylactic acid parts","volume":"102","author":"Liu","year":"2019","journal-title":"Int J Adv Manuf Technol"},{"issue":"10","key":"10.1016\/j.pharma.2026.01.007_bib1705","first-page":"4087","article-title":"New publicly available chemical query language, CSRML, to support chemotype representations for application to data mining and modeling","volume":"59","author":"Yang","year":"2019","journal-title":"J Chem Info Model"},{"issue":"1","key":"10.1016\/j.pharma.2026.01.007_bib1710","doi-asserted-by":"crossref","first-page":"28422","DOI":"10.1038\/s41598-024-79749-6","article-title":"Computational analysis of controlled drug release from porous polymeric carrier with the aid of Mass transfer and artificial intelligence modeling","volume":"14","author":"Alshahrani","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.pharma.2026.01.007_bib1715","doi-asserted-by":"crossref","first-page":"123017","DOI":"10.1016\/j.ijpharm.2023.123017","article-title":"Weibull \u03b2 value for the discernment of drug release mechanism of PLGA particles","volume":"640","author":"Mart\u00edn-Camacho","year":"2023","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.pharma.2026.01.007_bib1720","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4103\/ajprhc.ajprhc_68_25","article-title":"The role of artificial intelligence in the development of modern drug delivery systems","volume":"17","author":"Khalifa","year":"2025","journal-title":"Asian J Pharm Res Health Care"},{"issue":"9","key":"10.1016\/j.pharma.2026.01.007_bib1725","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S0169-409X(03)00119-4","article-title":"Application of artificial neural networks in the design of controlled release drug delivery systems","volume":"55","author":"Sun","year":"2003","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.pharma.2026.01.007_bib1730","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ejpb.2020.05.012","article-title":"Artificial neural networks applied to quality-by-design: from formulation development to clinical outcome","volume":"152","author":"Sim\u00f5es","year":"2020","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.pharma.2026.01.007_bib1735","first-page":"2715","article-title":"Basics of pharmaceutical emulsions: a review","volume":"5","author":"Khan","year":"2011","journal-title":"Afr J Pharm Pharmacol"},{"key":"10.1016\/j.pharma.2026.01.007_bib1740","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.colsurfa.2012.10.005","article-title":"Hybrid neural networks as tools for predicting the phase behavior of colloidal systems","volume":"415","author":"Agatonovic-Kustrin","year":"2012","journal-title":"Colloids Surf A Physicochem Eng Aspects"},{"key":"10.1016\/j.pharma.2026.01.007_bib1745","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1023\/B:PHAM.0000003372.56993.39","article-title":"Prediction of a stable microemulsion formulation for the oral delivery of a combination of antitubercular drugs using ANN methodology","volume":"20","author":"Agatonovic-Kustrin","year":"2003","journal-title":"Pharm Res"},{"key":"10.1016\/j.pharma.2026.01.007_bib1750","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1145\/1656274.1656280","article-title":"KNIME\u00a0\u2013\u00a0the Konstanz Information Miner: version 2.0 and beyond","volume":"11","author":"Berthold","year":"2009","journal-title":"SIGKDD Explor Newsl"},{"key":"10.1016\/j.pharma.2026.01.007_bib1755","series-title":"Next-generation drug delivery systems","first-page":"499","article-title":"Artificial intelligence and machine learning in drug delivery optimization","author":"Asediya","year":"2025"},{"issue":"1","key":"10.1016\/j.pharma.2026.01.007_bib1760","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/17425247.2019.1551875","article-title":"Use of computational fluid dynamics deposition modeling in respiratory drug delivery","volume":"16","author":"Longest","year":"2019","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.pharma.2026.01.007_bib1765","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.media.2017.07.005","article-title":"A survey on deep learning in medical image analysis","volume":"42","author":"Litjens","year":"2017","journal-title":"Med Image Anal"},{"key":"10.1016\/j.pharma.2026.01.007_bib1770","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fenvs.2015.00080","article-title":"DeepTox: toxicity prediction using deep learning","volume":"3","author":"Mayr","year":"2016","journal-title":"Front Environ Sci"},{"issue":"6","key":"10.1016\/j.pharma.2026.01.007_bib1775","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41573-019-0024-5","article-title":"Applications of machine learning in drug discovery and development","volume":"18","author":"Vamathevan","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.pharma.2026.01.007_bib1780","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.3390\/pharmaceutics15071916","article-title":"Artificial intelligence in pharmaceutical technology and drug delivery design","volume":"15","author":"Vora","year":"2023","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.pharma.2026.01.007_bib1785","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/cpt196673362","article-title":"Kinetics of pharmacologic effects","volume":"7","author":"Levy","year":"1966","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharma.2026.01.007_bib1790","doi-asserted-by":"crossref","first-page":"E60","DOI":"10.1208\/aapsj0901007","article-title":"A survey of population analysis methods and software for complex pharmacokinetic and pharmacodynamic models with examples","volume":"9","author":"Bauer","year":"2007","journal-title":"AAPS J"},{"issue":"4","key":"10.1016\/j.pharma.2026.01.007_bib1795","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/psp4.12500","article-title":"Efficient pharmacokinetic modeling workflow with the MonolixSuite: a case study of remifentanil","volume":"9","author":"Traynard","year":"2020","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"10.1016\/j.pharma.2026.01.007_bib1800","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1208\/s12249-015-0423-9","article-title":"Mathematical model-based accelerated development of extended-release metformin hydrochloride tablet formulation","volume":"17","author":"Chen","year":"2016","journal-title":"AAPS PharmSciTech"},{"issue":"6","key":"10.1016\/j.pharma.2026.01.007_bib1805","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s40262-019-00741-9","article-title":"Physiologically based pharmacokinetic modeling for first-in-human predictions: an updated model building strategy illustrated with challenging industry case studies","volume":"58","author":"Miller","year":"2019","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.pharma.2026.01.007_bib1810","doi-asserted-by":"crossref","first-page":"102546","DOI":"10.1016\/j.sbi.2023.102546","article-title":"Artificial intelligence for compound pharmacokinetics prediction","volume":"79","author":"Obrezanova","year":"2023","journal-title":"Curr Opin Struct Biol"},{"issue":"6","key":"10.1016\/j.pharma.2026.01.007_bib1815","doi-asserted-by":"crossref","first-page":"104360","DOI":"10.1016\/j.drudis.2025.104360","article-title":"Artificial intelligence in preclinical research: enhancing digital twins and organ-on-chip to reduce animal testing","volume":"30","author":"Gangwal","year":"2025","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.pharma.2026.01.007_bib1820","unstructured":"European Chemicals Agency. (n.d.). Understanding REACH. ECHA. [Retrieved June 10, 2025, from https:\/\/echa.europa.eu\/regulations\/reach\/understanding-reach]."},{"key":"10.1016\/j.pharma.2026.01.007_bib1825","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jhealeco.2016.01.012","article-title":"Innovation in the pharmaceutical industry: new estimates of R&D costs","volume":"47","author":"DiMasi","year":"2016","journal-title":"J Health Econ"},{"key":"10.1016\/j.pharma.2026.01.007_bib1830","doi-asserted-by":"crossref","first-page":"8857428","DOI":"10.1155\/2020\/8857428","article-title":"An overview of in vitro, in vivo, and computational techniques for cancer-associated angiogenesis studies","volume":"1","author":"Rahman","year":"2020","journal-title":"Biomed Res Int"},{"issue":"9","key":"10.1016\/j.pharma.2026.01.007_bib1835","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharma.2026.01.007_bib1840","unstructured":"National Institute of Environmental Health Sciences. (n.d.). Toxicology in the 21st Century (Tox21). U.S. Department of Health and Human Services. [Retrieved June 10, 2025, from https:\/\/www.niehs.nih.gov\/research\/programs\/tox21]."},{"key":"10.1016\/j.pharma.2026.01.007_bib1845","first-page":"463","article-title":"Modeling Tox21 data for toxicity prediction and mechanism deconvolution","author":"Xu","year":"2023","journal-title":"Mach Learn Deep Learn Comput Toxicol"},{"key":"10.1016\/j.pharma.2026.01.007_bib1850","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s11030-021-10217-3","article-title":"Artificial intelligence to deep learning: machine intelligence approach for drug discovery","volume":"25","author":"Gupta","year":"2021","journal-title":"Mol Divers"},{"key":"10.1016\/j.pharma.2026.01.007_bib1855","first-page":"73","article-title":"Drug-induced liver injury","volume":"6","author":"David","year":"2010","journal-title":"US Gastroenterol Hepatol Rev"},{"issue":"2","key":"10.1016\/j.pharma.2026.01.007_bib1860","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41573-019-0048-x","article-title":"Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive models","volume":"19","author":"Weaver","year":"2020","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"10.1016\/j.pharma.2026.01.007_bib1865","first-page":"100688","article-title":"Introduction to artificial intelligence and machine learning in pathology and medicine: Generative and nongenerative artificial intelligence basics","volume":"37","author":"Rashidi","year":"2024","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pharma.2026.01.007_bib1870","unstructured":"National Toxicology Program. (n.d.). NICEATM (NTP Interagency Center for the Evaluation of Alternative Toxicological Methods). National Institute of Environmental Health Sciences. [Retrieved, from https:\/\/ntp.niehs.nih.gov\/whatwestudy\/niceatm]."},{"key":"10.1016\/j.pharma.2026.01.007_bib1875","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.tiv.2019.01.004","article-title":"Prediction of the skin sensitizing potential and potency of compounds via mechanism-based binary and ternary classification models","volume":"59","author":"Di","year":"2019","journal-title":"Toxicol In Vitro"},{"issue":"19","key":"10.1016\/j.pharma.2026.01.007_bib1880","doi-asserted-by":"crossref","first-page":"12856","DOI":"10.3390\/ijerph191912856","article-title":"SkinSensPred as a promising in silico tool for integrated testing strategy on skin sensitization","volume":"19","author":"Wang","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.pharma.2026.01.007_bib1885","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3389\/fphar.2020.00639","article-title":"Dual transcriptomic and molecular machine learning predicts all major clinical forms of drug cardiotoxicity","volume":"11","author":"Mamoshina","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pharma.2026.01.007_bib1890","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12859-019-2814-5","article-title":"Computational determination of hERG-related cardiotoxicity of drug candidates","volume":"20","author":"Lee","year":"2019","journal-title":"BMC Bioinform"},{"key":"10.1016\/j.pharma.2026.01.007_bib1895","series-title":"Heartox\u00a0\u2013\u00a0Non-Profit Charity HTML Template","year":"2024"},{"issue":"2","key":"10.1016\/j.pharma.2026.01.007_bib1900","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/10590501.2016.1166879","article-title":"New clues on carcinogenicity-related substructures derived from mining two large datasets of chemical compounds","volume":"34","author":"Golbamaki","year":"2016","journal-title":"J Environ Sci Health C"},{"issue":"2","key":"10.1016\/j.pharma.2026.01.007_bib1905","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/toxsci\/kfy146","article-title":"Identification of nontoxic substructures: a new strategy to avoid potential toxicity risk","volume":"165","author":"Yang","year":"2018","journal-title":"Toxicol Sci"},{"issue":"1","key":"10.1016\/j.pharma.2026.01.007_bib1910","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1038\/s41598-017-02365-0","article-title":"CarcinoPred-EL: novel models for predicting the carcinogenicity of chemicals using molecular fingerprints and ensemble learning methods","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.pharma.2026.01.007_bib1915","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.yrtph.2018.01.008","article-title":"Combining machine learning models of in vitro and in vivo bioassays improves rat carcinogenicity prediction","volume":"94","author":"Guan","year":"2018","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.pharma.2026.01.007_bib1920","doi-asserted-by":"crossref","first-page":"110921","DOI":"10.1016\/j.fct.2019.110921","article-title":"CapsCarcino: a novel sparse data deep learning tool for predicting carcinogens","volume":"135","author":"Wang","year":"2020","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.pharma.2026.01.007_bib1925","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1590\/S1984-82502011000100005","article-title":"Alternative methods in toxicity testing: the current approach","volume":"50","author":"Ara\u00fajo","year":"2014","journal-title":"Braz J Pharm Sci"},{"issue":"11","key":"10.1016\/j.pharma.2026.01.007_bib1930","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1021\/ci300367a","article-title":"admetSAR: a comprehensive source and free tool for assessment of chemical ADMET properties","volume":"52","author":"Cheng","year":"2012","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.pharma.2026.01.007_bib1935","doi-asserted-by":"crossref","first-page":"100204","DOI":"10.1016\/j.comtox.2021.100204","article-title":"Evaluating confidence in toxicity assessments based on experimental data and in silico predictions","volume":"21","author":"Johnson","year":"2021","journal-title":"Comput Toxicol"},{"issue":"W1","key":"10.1016\/j.pharma.2026.01.007_bib1940","doi-asserted-by":"crossref","first-page":"W257","DOI":"10.1093\/nar\/gky318","article-title":"ProTox-II: a webserver for the prediction of toxicity of chemicals","volume":"46","author":"Banerjee","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"10.1016\/j.pharma.2026.01.007_bib1945","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/bioinformatics\/bty707","article-title":"admetSAR 2.0: web-service for prediction and optimization of chemical ADMET properties","volume":"35","author":"Yang","year":"2019","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.pharma.2026.01.007_bib1950","first-page":"189","article-title":"ProTox: a web server for the in-silico prediction of rodent oral toxicity","volume":"137","author":"Drwal","year":"2014","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.pharma.2026.01.007_bib1955","series-title":"Guidance document on the validation of (quantitative) structure-activity relationship [(Q)SAR] models","year":"2014"},{"key":"10.1016\/j.pharma.2026.01.007_bib1960","doi-asserted-by":"crossref","first-page":"103962","DOI":"10.1016\/j.chemolab.2020.103962","article-title":"A novel strategy for prediction of human plasma protein binding using machine learning techniques","volume":"199","author":"Yuan","year":"2020","journal-title":"Chemom Intell Lab Syst"},{"key":"10.1016\/j.pharma.2026.01.007_bib1965","doi-asserted-by":"crossref","first-page":"W270","DOI":"10.1093\/nar\/gkr366","article-title":"SwissDock, a protein-small molecule docking web service based on EADock DSS","volume":"39","author":"Grosdidier","year":"2011","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"10.1016\/j.pharma.2026.01.007_bib1970","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/nbt.3300","article-title":"Predicting the sequence specificities of DNA- and RNA-binding proteins by deep learning","volume":"33","author":"Alipanahi","year":"2015","journal-title":"Nat Biotechnol"},{"issue":"2","key":"10.1016\/j.pharma.2026.01.007_bib1975","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1177\/0300985812450727","article-title":"History of chronic toxicity and animal carcinogenicity studies for pharmaceuticals","volume":"50","author":"Jacobs","year":"2013","journal-title":"Vet Pathol"},{"issue":"6","key":"10.1016\/j.pharma.2026.01.007_bib1980","first-page":"169E","article-title":"Applicability of QSAR analysis in the evaluation of developmental and neurotoxicity effects for the assessment of the toxicological relevance of metabolites and degradates of pesticide active substances for dietary risk assessment","volume":"8","author":"Worth","year":"2009","journal-title":"EFSA Support Publ"},{"issue":"66","key":"10.1016\/j.pharma.2026.01.007_bib1985","doi-asserted-by":"crossref","first-page":"41330","DOI":"10.1039\/C7RA08415C","article-title":"In silico prediction of chronic toxicity with chemical category approaches","volume":"7","author":"Li","year":"2017","journal-title":"RSC Adv"},{"issue":"2","key":"10.1016\/j.pharma.2026.01.007_bib1990","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0167-6296(02)00126-1","article-title":"The price of innovation: new estimates of drug development costs","volume":"22","author":"DiMasi","year":"2003","journal-title":"J Health Econ"},{"issue":"8","key":"10.1016\/j.pharma.2026.01.007_bib1995","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.tips.2019.05.005","article-title":"Artificial intelligence for clinical trial design","volume":"40","author":"Harrer","year":"2019","journal-title":"Trends Pharmacol Sci"},{"issue":"10","key":"10.1016\/j.pharma.2026.01.007_bib2000","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.chembiol.2016.07.023","article-title":"A data-driven approach to predicting successes and failures of clinical trials","volume":"23","author":"Gayvert","year":"2016","journal-title":"Cell Chem Biol"},{"issue":"1","key":"10.1016\/j.pharma.2026.01.007_bib2005","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s11266-021-00400-3","article-title":"Transcription and qualitative methods: implications for third sector research","volume":"34","author":"McMullin","year":"2021","journal-title":"Voluntas"},{"key":"10.1016\/j.pharma.2026.01.007_bib2010","doi-asserted-by":"crossref","first-page":"903600","DOI":"10.3389\/fgene.2022.903600","article-title":"Explainability in medicine in an era of AI-based clinical decision support systems","volume":"13","author":"Pierce","year":"2022","journal-title":"Front Genet"},{"issue":"2","key":"10.1016\/j.pharma.2026.01.007_bib2015","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s12599-019-00624-0","article-title":"Digital Twin: empowering enterprises towards a system-of-systems approach: M. Dietz and G. Pernul","volume":"62","author":"Dietz","year":"2020","journal-title":"Bus Info Syst Eng"},{"issue":"7","key":"10.1016\/j.pharma.2026.01.007_bib2020","doi-asserted-by":"crossref","first-page":"e13897","DOI":"10.1111\/cts.13897","article-title":"Increasing acceptance of AI-generated digital twins through clinical trial applications","volume":"17","author":"Vidovszky","year":"2024","journal-title":"Clin Transl Sci"},{"issue":"3","key":"10.1016\/j.pharma.2026.01.007_bib2025","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/cpt.16","article-title":"The future is now: model-based clinical trial design for Alzheimer's disease","volume":"97","author":"Romero","year":"2015","journal-title":"Clin Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.pharma.2026.01.007_bib2030","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.3390\/electronics12071509","article-title":"Machine learning and AI technologies for smart wearables","volume":"12","author":"Seng","year":"2023","journal-title":"Electronics"},{"issue":"11","key":"10.1016\/j.pharma.2026.01.007_bib2035","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1016\/j.drudis.2021.06.009","article-title":"AI-based language models powering drug discovery and development","volume":"26","author":"Liu","year":"2021","journal-title":"Drug Discov Today"},{"issue":"9","key":"10.1016\/j.pharma.2026.01.007_bib2040","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1080\/17434440.2020.1813566","article-title":"Toward standardized premarket evaluation of computer aided diagnosis\/detection products: insights from FDA82 approved products","volume":"17","author":"Wang","year":"2020","journal-title":"Expert Rev Med Devices"},{"issue":"1","key":"10.1016\/j.pharma.2026.01.007_bib2045","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.drudis.2018.07.007","article-title":"Translational in vitro research: integrating 3D drug discovery and development processes into the drug development pipeline","volume":"24","author":"Kelm","year":"2019","journal-title":"Drug Discov Today"},{"issue":"1","key":"10.1016\/j.pharma.2026.01.007_bib2050","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/1040638717738276","article-title":"A review of medical terminology standards and structured reporting","volume":"30","author":"Awaysheh","year":"2018","journal-title":"J Vet Diagn Invest"},{"issue":"1","key":"10.1016\/j.pharma.2026.01.007_bib2055","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1055\/s-0038-1667077","article-title":"Recent developments in clinical terminologies\u2014SNOMED CT, LOINC, and RxNorm","volume":"27","author":"Bodenreider","year":"2018","journal-title":"Yearb Med Inform"},{"issue":"1","key":"10.1016\/j.pharma.2026.01.007_bib2060","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1208\/s12248-024-01006-5","article-title":"Innovative approaches in regulatory affairs: leveraging artificial intelligence and machine learning for efficient compliance and decision-making","volume":"27","author":"Ajmal","year":"2025","journal-title":"AAPS J"},{"key":"10.1016\/j.pharma.2026.01.007_bib2065","series-title":"Linguamatics natural language processing for regulatory intelligence [Internet]","year":"2024"},{"issue":"01","key":"10.1016\/j.pharma.2026.01.007_bib2070","doi-asserted-by":"crossref","first-page":"603","DOI":"10.30574\/ijsra.2025.14.1.0124","article-title":"The impact of artificial intelligence on legal practice: enhancing legal research, contract analysis, and predictive justice","volume":"14","author":"Emejuo","year":"2024","journal-title":"Int J Sci Res Arch"},{"issue":"3","key":"10.1016\/j.pharma.2026.01.007_bib2075","doi-asserted-by":"crossref","first-page":"969","DOI":"10.30574\/wjarr.2025.25.3.0814","article-title":"Navigating the intersection of US regulatory frameworks and artificial intelligence: strategies for ethical compliance","volume":"25","author":"Agbadamasi","year":"2025","journal-title":"World J Adv Res Rev"},{"key":"10.1016\/j.pharma.2026.01.007_bib2080","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.chemosphere.2017.04.084","article-title":"Eco-pharmacovigilance of non-steroidal antiinflammatory drugs: necessity and opportunities","volume":"181","author":"He","year":"2017","journal-title":"Chemosphere"},{"issue":"2","key":"10.1016\/j.pharma.2026.01.007_bib2085","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1016\/S2589-7500(21)00229-6","article-title":"Key use cases for artificial intelligence to reduce the frequency of adverse drug events: a scoping review","volume":"4","author":"Syrowatka","year":"2022","journal-title":"Lancet Digit Health"},{"issue":"10","key":"10.1016\/j.pharma.2026.01.007_bib2090","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/nrd3002","article-title":"New approaches to drug safety: a pharmacovigilance tool kit","volume":"8","author":"Wise","year":"2009","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"10.1016\/j.pharma.2026.01.007_bib2095","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1007\/s11030-021-10326-z","article-title":"Artificial intelligence and machine learning approaches for drug design: challenges and opportunities for the pharmaceutical industries","volume":"26","author":"Selvaraj","year":"2022","journal-title":"Mol Diversity"},{"key":"10.1016\/j.pharma.2026.01.007_bib2100","series-title":"A handbook of artificial intelligence in drug delivery","first-page":"395","article-title":"Artificial intelligence (AI) in drug product designing, development, and manufacturing","author":"Chaudhary","year":"2023"},{"issue":"14","key":"10.1016\/j.pharma.2026.01.007_bib2105","doi-asserted-by":"crossref","first-page":"6591","DOI":"10.3390\/su17146591","article-title":"A systematic review of artificial intelligence (AI) and machine learning (ML) in pharmaceutical supply chain (PSC) resilience: current trends and future directions","volume":"17","author":"Al-Hourani","year":"2025","journal-title":"Sustainability"},{"issue":"2","key":"10.1016\/j.pharma.2026.01.007_bib2110","article-title":"The transformative power of artificial intelligence in pharmaceutical manufacturing: Enhancing efficiency, product quality, and safety","volume":"6","author":"Rajesh","year":"2025","journal-title":"J Holist Integr Pharm"},{"key":"10.1016\/j.pharma.2026.01.007_bib2115","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s42256-022-00516-1","article-title":"Advances, challenges and opportunities in creating data for trustworthy AI","volume":"4","author":"Liang","year":"2022","journal-title":"Nat Mach Intell"},{"key":"10.1016\/j.pharma.2026.01.007_bib2120","doi-asserted-by":"crossref","first-page":"100268","DOI":"10.1016\/j.greeac.2025.100268","article-title":"From discovery to delivery: governance of AI in the pharmaceutical industry","volume":"13","author":"Pasas-Farmer","year":"2025","journal-title":"Green Anal Chem"},{"key":"10.1016\/j.pharma.2026.01.007_bib2125","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12910-024-01062-8","article-title":"Ethical considerations and concerns in the implementation of AI in pharmacy practice: a cross-sectional study","volume":"25","author":"Hasan","year":"2024","journal-title":"BMC Med Ethics"},{"key":"10.1016\/j.pharma.2026.01.007_bib2130","unstructured":"U.S. Food and Drug Administration. FDA Releases Artificial Intelligence\/Machine Learning Action Plan. FDA.gov. https:\/\/www.fda.gov\/news-events\/pressannouncements\/fda-releases-artificial-intelligencemachine-learning-action-plan."},{"key":"10.1016\/j.pharma.2026.01.007_bib2135","first-page":"100686","article-title":"Ethical and bias considerations in artificial intelligence\/machine learning","volume":"37","author":"Hanna","year":"2024","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.pharma.2026.01.007_bib2140","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3390\/ph18010047","article-title":"Harnessing the AI\/ML in drug and biological products discovery and development: the regulatory perspective","volume":"18","author":"Mirakhori","year":"2025","journal-title":"Pharmaceuticals"},{"issue":"8","key":"10.1016\/j.pharma.2026.01.007_bib2145","doi-asserted-by":"crossref","first-page":"22115","DOI":"10.1002\/ddr.22115","article-title":"Artificial intelligence revolutionizing drug development: exploring opportunities and challenges","volume":"84","author":"Tiwari","year":"2023","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.pharma.2026.01.007_bib2150","doi-asserted-by":"crossref","first-page":"100347","DOI":"10.1016\/j.patter.2021.100347","article-title":"Addressing bias in big data and AI for health care: a call for open science","volume":"2","author":"Norori","year":"2021","journal-title":"Patterns"},{"key":"10.1016\/j.pharma.2026.01.007_bib2155","series-title":"Chapman and Hall\/CRC","first-page":"23","article-title":"Trends and advancements of AI and XAI in drug discovery. Explainable AI (XAI) for sustainable development","author":"Chandak","year":"2024"},{"key":"10.1016\/j.pharma.2026.01.007_bib2160","first-page":"10326","article-title":"Artificial intelligence in drug development and delivery: opportunities, challenges, and future directions","volume":"8","author":"Mondal","year":"2024","journal-title":"J Angiother"},{"key":"10.1016\/j.pharma.2026.01.007_bib2165","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.clinthera.2019.05.018","article-title":"A study on the application and use of artificial intelligence to support drug development","volume":"41","author":"Lamberti","year":"2019","journal-title":"Clin Ther"},{"key":"10.1016\/j.pharma.2026.01.007_bib2170","series-title":"Computational approaches for novel therapeutic and diagnostic designing to mitigate SARS-CoV-2 infection","first-page":"335","article-title":"Absorption, distribution, metabolism, excretion, and toxicity assessment of drugs using computational tools","author":"Sucharitha","year":"2022"},{"key":"10.1016\/j.pharma.2026.01.007_bib2175","doi-asserted-by":"crossref","first-page":"100529","DOI":"10.1016\/j.aimed.2025.100529","article-title":"AI-driven clinical decision support systems: revolutionizing medication selection and personalized drug therapy","volume":"12","author":"Khude","year":"2025","journal-title":"Adv Integr Med"},{"key":"10.1016\/j.pharma.2026.01.007_bib2180","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1080\/17460441.2020.1745183","article-title":"The power of deep learning for ligand-based novel drug discovery","volume":"15","author":"Baskin","year":"2020","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.pharma.2026.01.007_bib2185","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/jcc.24764","article-title":"Deep learning for computational chemistry","volume":"38","author":"Goh","year":"2017","journal-title":"J Comput Chem"},{"issue":"D1","key":"10.1016\/j.pharma.2026.01.007_bib2190","doi-asserted-by":"crossref","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: a major update to the DrugBank database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.pharma.2026.01.007_bib2195","doi-asserted-by":"crossref","first-page":"D552","DOI":"10.1093\/nar\/gkp937","article-title":"STITCH 2: an interaction network database for small molecules and proteins","volume":"38","author":"Kuhn","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.pharma.2026.01.007_bib2200","doi-asserted-by":"crossref","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","article-title":"KEGG: new perspectives on genomes, pathways, diseases and drugs","volume":"45","author":"Kanehisa","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.pharma.2026.01.007_bib2205","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1021\/acs.jcim.0c00675","article-title":"ZINC20\u2014a free ultralarge-scale chemical database for ligand discovery","volume":"60","author":"Irwin","year":"2020","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.pharma.2026.01.007_bib2210","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1093\/nar\/gkv951","article-title":"PubChem substance and compound databases","volume":"44","author":"Kim","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.pharma.2026.01.007_bib2215","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1080\/07391102.2020.1745279","article-title":"In-silico identification of peroxisome proliferator-activated receptor (PPAR) \u03b1\/\u03b3 agonists from ligand expo components database","volume":"39","author":"Feng","year":"2020","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.pharma.2026.01.007_bib2220","doi-asserted-by":"crossref","first-page":"W612","DOI":"10.1093\/nar\/gkv352","article-title":"ChEMBL web services: streamlining access to drug discovery data and utilities","volume":"43","author":"Davies","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.pharma.2026.01.007_bib2225","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.procs.2022.12.148","article-title":"Towards a more general drug target interaction prediction model using transfer learning","volume":"216","author":"Suhartono","year":"2023","journal-title":"Procedia Comput Sci"},{"key":"10.1016\/j.pharma.2026.01.007_bib2230","unstructured":"SwissADME. SwissADME, Swiss Institute of Bioinformatics, http:\/\/www.swissadme.ch\/."},{"key":"10.1016\/j.pharma.2026.01.007_bib2235","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1186\/s12859-020-03724-x","article-title":"DPDDI: a deep predictor for drug-drug interactions","volume":"21","author":"Feng","year":"2020","journal-title":"BMC Bioinform"},{"key":"10.1016\/j.pharma.2026.01.007_bib2240","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1021\/acs.jcim.8b00524","article-title":"Polypharmacology browser PPB2: target prediction combining nearest neighbors with machine learning","volume":"59","author":"Awale","year":"2018","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.pharma.2026.01.007_bib2245","doi-asserted-by":"crossref","first-page":"D919","DOI":"10.1093\/nar\/gkm862","article-title":"SuperTarget and Matador: resources for exploring drug-target relationships","volume":"36","author":"G\u00fcnther","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.pharma.2026.01.007_bib2250","unstructured":"Streamline Clinical Trials with AI and Digital Twins of Patients. [Accessed 2 June 2025, https:\/\/www.unlearn.ai\/]."},{"key":"10.1016\/j.pharma.2026.01.007_bib2255","unstructured":"#1 in AI Clinical Analytics (no date) www.saama.com. [Accessed 2 June 2025. Available at: https:\/\/www.saama.com\/]."},{"key":"10.1016\/j.pharma.2026.01.007_bib2260","unstructured":"Leading Clinical Trials AI Software\u00a0\u2013\u00a0Deep6 AI (2024) Deep6.ai. [Accessed 2 June 2025. Available at: https:\/\/www.deep6.ai\/]."},{"key":"10.1016\/j.pharma.2026.01.007_bib2265","series-title":"Trials. ai\u2013Our Smart Protocol technology helps teams design better clinical trials with AI","author":"Trials","year":"2019"},{"key":"10.1016\/j.pharma.2026.01.007_bib2270","series-title":"Medidata AI: clinical trial analytics [Internet]","year":"2024"},{"key":"10.1016\/j.pharma.2026.01.007_bib2275","unstructured":"IBM. IBM Watson for Clinical Trial Matching [Internet]. Armonk (NY): IBM Corporation. [Accessed 2 June 2025. Available from: https:\/\/www.ibm.com\/products\/clinicaldevelopment]."},{"key":"10.1016\/j.pharma.2026.01.007_bib2280","series-title":"Linguamatics NLP for Real-World Evidence [Internet]","year":"2024"},{"key":"10.1016\/j.pharma.2026.01.007_bib2285","series-title":"Aetion Evidence Platform [Internet]","year":"2024"},{"key":"10.1016\/j.pharma.2026.01.007_bib2290","series-title":"Global Real-World Data Network [Internet]","year":"2024"},{"key":"10.1016\/j.pharma.2026.01.007_bib2295","series-title":"AiCure: digital medication adherence [Internet]","year":"2024"},{"key":"10.1016\/j.pharma.2026.01.007_bib2300","series-title":"Pharma. AI Whitepaper","year":"2023"},{"key":"10.1016\/j.pharma.2026.01.007_bib2305","series-title":"Advanced Analytics for Pharma","year":"2023"},{"key":"10.1016\/j.pharma.2026.01.007_bib2310","first-page":"2342","article-title":"Pharmaceutical applications of artificial intelligence","volume":"6","author":"Sable","year":"2018","journal-title":"Int J Pharma Res Health Sci"},{"key":"10.1016\/j.pharma.2026.01.007_bib2315","series-title":"AI innovations in drug delivery and pharmaceutical sciences; advancing therapy through technology","first-page":"163","article-title":"Role of artificial intelligence in drug product design and optimization of process parameters","author":"Pandey","year":"2024"},{"key":"10.1016\/j.pharma.2026.01.007_bib2320","series-title":"EZAI Technical Report","year":"2023"},{"key":"10.1016\/j.pharma.2026.01.007_bib2325","series-title":"AIM for Biopharma","year":"2023"},{"key":"10.1016\/j.pharma.2026.01.007_bib2330","first-page":"1","article-title":"Artificial intelligence-assisted analytical method development","volume":"1","author":"Kumar","year":"2025","journal-title":"Ind J Pharm Chem Anal Techn"},{"key":"10.1016\/j.pharma.2026.01.007_bib2335","series-title":"SynTQ PAT Brochure","year":"2023"},{"key":"10.1016\/j.pharma.2026.01.007_bib2340","series-title":"Granta MI for Pharma","year":"2023"},{"key":"10.1016\/j.pharma.2026.01.007_bib2345","series-title":"RegAssist Product Sheet","year":"2023"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450926000076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450926000076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T23:20:45Z","timestamp":1781220045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003450926000076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":270,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0003450926000076"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2026.01.007","relation":{},"ISSN":["0003-4509"],"issn-type":[{"value":"0003-4509","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A review exploring the translational perspective of artificial intelligence in drug discovery and formulation development","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2026.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Acad\u00e9mie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}